22 May 2013
Keywords: bayer/regeneron, begin, ph, iii, trap-eye, study, bayer
Article | 13 August 2007
Bayer Healthcare AG, a division of Germany's Bayer AG, and US drugmaker Regeneron Pharmaceuticals have initiated a Phase III study ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 August 2007
13 August 2007
21 May 2013
© 2013 thepharmaletter.com